Neogen (NASDAQ:NEOG) Shares Down 6.2% – Here’s What Happened

Neogen Corporation (NASDAQ:NEOG) dropped 6.2% on Tuesday. The company traded as low as $12.24 and last traded at $12.2090. Approximately 1,448,207 shares changed hands during trading, a decline of 50% from the average session volume of 2,881,252 shares. The stock had previously closed at $13.01.

Key Headlines Impacting Neogen

Here are the key news stories impacting Neogen this week:

• Positive Sentiment: Neogen’s fiscal first-quarter revenue rose 6.5% year over year to $222.8 million, exceeding the $208.2 million consensus estimate. Adjusted EPS of $0.08 also surpassed expectations of $0.05, compared with $0.04 a year earlier. Neogen Q1 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised fiscal 2027 revenue guidance to $885 million-$890 million and adjusted EBITDA guidance to $181 million-$183 million, while Food Safety revenue increased 7.4% and Animal Safety revenue rose 4.2%. Neogen Q1 Revenue Rises and Raises FY27 Outlook
• Positive Sentiment: At its 2026 Investor Day, Neogen outlined a strategy focused on profitable growth, innovation and margin expansion through fiscal 2031. The planned Petrifilm manufacturing transition is expected to begin in November, and the company highlighted its food-safety market position and long-term growth framework. Neogen Investor Day Strategy
• Negative Sentiment: The primary overhang is an FDA warning related to recalled Neogen Vet product HYCOAT, which reports have linked to fungal contamination and at least 20 horse deaths. Law firms including Levi & Korsinsky and Pomerantz have announced investigations, raising potential liability, reputational and legal-cost risks. Neogen Securities Investigation Notice

Wall Street Analyst Weigh In

A number of equities analysts have commented on NEOG shares. Weiss Ratings upgraded shares of Neogen from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 7th. Guggenheim restated a “buy” rating and issued a $14.00 price target (up from $12.00) on shares of Neogen in a report on Wednesday, September 30th. Wall Street Zen raised shares of Neogen from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 3rd. Finally, Piper Sandler upgraded shares of Neogen from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $13.00 to $14.00 in a research note on Wednesday, August 26th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $12.67.

Neogen Trading Down 2.3%

The company has a 50 day moving average of $12.12 and a two-hundred day moving average of $10.27. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.91 and a current ratio of 3.82. The stock has a market capitalization of $2.55 billion, a PE ratio of -46.72, a P/E/G ratio of 4.48 and a beta of 1.79.

Neogen (NASDAQ:NEOG) last released its quarterly earnings results on Tuesday, October 6th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03. The company had revenue of $222.80 million during the quarter, compared to analysts’ expectations of $208.18 million. Neogen had a positive return on equity of 3.28% and a negative net margin of 6.35%.The firm’s revenue was up 6.5% compared to the same quarter last year. During the same period last year, the business posted $0.04 earnings per share. Sell-side analysts predict that Neogen Corporation will post 0.27 EPS for the current year.

Hedge Funds Weigh In On Neogen

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Values First Advisors Inc. grew its stake in shares of Neogen by 2.2% in the first quarter. Values First Advisors Inc. now owns 90,238 shares of the company’s stock worth $838,000 after acquiring an additional 1,917 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Neogen by 3.1% in the first quarter. The Manufacturers Life Insurance Company now owns 96,859 shares of the company’s stock valued at $900,000 after acquiring an additional 2,869 shares in the last quarter. Nykredit A S purchased a new position in Neogen in the second quarter valued at $28,000. Public Employees Retirement System of Ohio purchased a new position in Neogen in the second quarter valued at $34,000. Finally, Corient Private Wealth LP grew its stake in Neogen by 9.1% during the 2nd quarter. Corient Private Wealth LP now owns 46,474 shares of the company’s stock worth $418,000 after purchasing an additional 3,859 shares in the last quarter. 96.73% of the stock is owned by hedge funds and other institutional investors.

About Neogen

Neogen Corporation is a global provider of food safety and animal safety products and services. The company develops diagnostic tests, laboratory products, and related solutions that help customers detect foodborne pathogens, allergens, toxins, residues, and other contaminants throughout the food production process.

Its food safety portfolio includes test kits, culture media, molecular testing systems, sanitation monitoring products, and laboratory supplies used by food manufacturers, processors, retailers, and regulatory organizations.